CFM Resolution 2.454/2026: Brazil
CFM Resolution 2.454/2026 governs responsible medical use of AI in Brazil. The physician remains the final clinical decision-maker and must assess the actual use, inform the patient when required, document AI support as required, and review every output.
Relevant Maestra measures
Section titled “Relevant Maestra measures”- Generated notes and assistant replies remain drafts for professional review. They do not make autonomous diagnostic, prognostic, or prescriptive decisions.
- Sensitive stored clinical values are encrypted on-device. Necessary audio and clinical text pass transiently through the relay and contracted processors for the requested task.
- Before transcription, the app requires the clinician to confirm a once-per-encounter consent attestation. The client stores the attestation timestamp as structural metadata. It does not capture a consent method.
- The physician can edit or disregard generated content and remains responsible for the final record.
Physician and institution responsibilities
Section titled “Physician and institution responsibilities”The physician must deliver any required patient disclosure, decide whether the attestation accurately reflects consent, document AI use in the clinical record when required, assess risk, verify clinical accuracy, and follow institutional governance rules. Maestra’s timestamp does not prove the content or method of the consent conversation.

